ELICIO THERAPEUTICS INC (ELTX:NASDAQ)
$11.98 -0.2 (-1.642%)
Analysed ELICIO THERAPEUTICS INC (ELTX:NASDAQ) News Sources
Elicio Therapeutics Reports Inducement Grants
16-04-2026
yahoo.com
Is Aura Biosciences (AURA) Outperforming Other Medical Stocks This Year?
20-03-2026
yahoo.com
Wall Street Analysts Predict a 42.28% Upside in Elicio Therapeutics (ELTX): Here's What You Should Know
18-03-2026
yahoo.com
Elicio Therapeutics: Q4 Earnings Snapshot
12-03-2026
yahoo.com
Elicio Therapeutics Reports Full Year 2025 Financial Results and Provides Corporate Updates
12-03-2026
yahoo.com
Elicio Therapeutics to Present at the TD Cowen 46th Annual Health Care Conference
25-02-2026
yahoo.com
While insiders own 33% of Elicio Therapeutics, Inc. (NASDAQ:ELTX), individual investors are its largest shareholders with 55% ownership
28-01-2026
yahoo.com
Elicio Therapeutics (ELTX) Upgraded to Buy: Here's Why
11-12-2025
yahoo.com
Elicio Therapeutics Reports Antigen Spreading to Patient-Specific Neoantigens Beyond mKRAS in Ongoing Phase 2 AMPLIFY-7P Trial
11-12-2025
yahoo.com
Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight
10-12-2025
yahoo.com
What is the current price of ELICIO THERAPEUTICS INC (ELTX:NASDAQ)?
The current price of ELICIO THERAPEUTICS INC (ELTX:NASDAQ) is $11.98.
ELICIO THERAPEUTICS INC (ELTX:NASDAQ) absolute price change since previous trading day?
The absolute price change of ELICIO THERAPEUTICS INC (ELTX:NASDAQ) since the previous trading day is $-0.2.
ELICIO THERAPEUTICS INC (ELTX:NASDAQ) percentage price change since previous trading day?
The percentage price change of ELICIO THERAPEUTICS INC (ELTX:NASDAQ) since the previous trading day is -1.642%.
What is the most recent average sentiment score for ELICIO THERAPEUTICS INC (ELTX:NASDAQ)?
The most recent average sentiment score for ELICIO THERAPEUTICS INC (ELTX:NASDAQ) is 83 out of 100.
What is the most recent average sentiment for ELICIO THERAPEUTICS INC (ELTX:NASDAQ)?
The most recent sentiment for ELICIO THERAPEUTICS INC (ELTX:NASDAQ) is .
SEC-8K** Filing Available For ELICIO THERAPEUTICS INC (ELTX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.